Skip Navigation LinksHome > October 2012 - Volume 20 - Issue 5 > Endolymphatic hydrops perspectives 2012
Current Opinion in Otolaryngology & Head & Neck Surgery:
doi: 10.1097/MOO.0b013e328357a6c8
HEARING SCIENCE AND VESTIBULAR MEDICINE: Edited by Rodney C. Diaz and Mohamed A. Hamid

Endolymphatic hydrops perspectives 2012

Pierce, Nathan E.; Antonelli, Patrick J.

Collapse Box


Purpose of review: Endolymphatic hydrops remains a significant cause of morbidity secondary to vertigo, hearing loss, and tinnitus. The purpose of this report is to summarize the most clinically relevant publications on endolymphatic hydrops over the past 2 years.

Recent findings: Hydrops has historically been a diagnosis of exclusion, but recent efforts has shown a role for MRI with intratympanic gadolinium. Cochrane reviews of intratympanic dexamethasone and gentamicin found inadequate level 1 evidence to support their use.

Summary: High-level evidence to guide therapy is lacking. MRI holds potential for definitive diagnosis.

© 2012 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.